Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

548 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
How does blood glucose control with insulin save lives in intensive care?
Van den Berghe G. Van den Berghe G. J Clin Invest. 2004 Nov;114(9):1187-95. doi: 10.1172/JCI23506. J Clin Invest. 2004. PMID: 15520847 Free PMC article. Review.
Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.
Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1995 Oct;43(4):457-63. doi: 10.1111/j.1365-2265.1995.tb02618.x. Clin Endocrinol (Oxf). 1995. PMID: 7586621 Clinical Trial.
Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine.
Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1994 Nov;41(5):563-9. doi: 10.1111/j.1365-2265.1994.tb01819.x. Clin Endocrinol (Oxf). 1994. PMID: 7828343 Clinical Trial.
Dopamine and the sick euthyroid syndrome in critical illness.
Van den Berghe G, de Zegher F, Lauwers P. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1994 Dec;41(6):731-7. doi: 10.1111/j.1365-2265.1994.tb02787.x. Clin Endocrinol (Oxf). 1994. PMID: 7889608 Clinical Trial.
Dopamine suppresses pituitary function in infants and children.
Van den Berghe G, de Zegher F, Lauwers P. Van den Berghe G, et al. Crit Care Med. 1994 Nov;22(11):1747-53. Crit Care Med. 1994. PMID: 7956277 Clinical Trial.
Growth hormone secretion in critical illness: effect of dopamine.
Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Van den Berghe G, et al. J Clin Endocrinol Metab. 1994 Oct;79(4):1141-6. doi: 10.1210/jcem.79.4.7962286. J Clin Endocrinol Metab. 1994. PMID: 7962286 Clinical Trial.
Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
Van den Berghe G, de Zegher F, Vlasselaers D, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Crit Care Med. 1996 Apr;24(4):590-5. doi: 10.1097/00003246-199604000-00007. Crit Care Med. 1996. PMID: 8612408 Clinical Trial.
Anterior pituitary function during critical illness and dopamine treatment.
Van den Berghe G, de Zegher F. Van den Berghe G, et al. Crit Care Med. 1996 Sep;24(9):1580-90. doi: 10.1097/00003246-199609000-00024. Crit Care Med. 1996. PMID: 8797634 Review.
Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1996 Sep;45(3):341-51. doi: 10.1046/j.1365-2265.1996.00805.x. Clin Endocrinol (Oxf). 1996. PMID: 8949573 Clinical Trial.
Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit.
Verwaest C, Verhaegen J, Ferdinande P, Schetz M, Van den Berghe G, Verbist L, Lauwers P. Verwaest C, et al. Among authors: van den berghe g. Crit Care Med. 1997 Jan;25(1):63-71. doi: 10.1097/00003246-199701000-00014. Crit Care Med. 1997. PMID: 8989178 Clinical Trial.
548 results
Jump to page
Feedback